- Investigator
- Mehdi S Mirsaeidi
- Status
- Accepting Candidates
- Ages
- 18 Years - 75 Years
- Sexes
- All
Treats Adults
Mehdi S Mirsaeidi, MD, MPH
Pulmonologist, Critical Care Medicine Physician
Mehdi S Mirsaeidi, MD, MPH
- Additional languages:
- Persian
Request appointment online
Research at a glance
Top areas of exploration
- Mycobacterium tuberculosis , 21 publications
- Antitubercular Agents , 20 publications
- COVID-19 , 18 publications
- Tuberculosis, Pulmonary , 15 publications
Research activity
Active clinical trials
- Investigator
- Mehdi S Mirsaeidi
- Status
- Accepting Candidates
- Ages
- 30 Years - NA Years
- Sexes
- All
- Investigator
- Mehdi S Mirsaeidi
- Status
- Accepting Candidates
- Ages
- 18 Years - 85 Years
- Sexes
- All
My publications
Filter publications
241 publications
2024
Proposing the potential of utilizing the CAT score for early detection of COPD in asymptomatic patients, shifting towards a patient-centered approach: A review
Medicine
2024
Risk of 30-Day All-Cause Readmission in Interstitial Lung Disease Patients after COVID-19: National-Level Data
Annals of the American Thoracic Society
2023
Acthar庐 Gel Treatment for Patients with Autoimmune and Inflammatory Diseases: An Historical Perspective and Characterization of Clinical Evidence.
Clinical drug investigation
鈥�2023
Clinical standards for diagnosis, treatment and prevention of post-COVID-19 lung disease.
The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease
鈥�2023
Sarcoidosis-associated pulmonary fibrosis: joining the dots.
European respiratory review : an official journal of the European Respiratory Society
鈥�